{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:45:05Z","timestamp":1791477905569,"version":"4.3.4"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T00:00:00Z","timestamp":1551225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T00:00:00Z","timestamp":1551225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Growing evidence implicates \u03b1-synuclein aggregation as a key driver of neurodegeneration in Parkinson\u2019s disease (PD) and other neurodegenerative disorders. Herein, the molecular and structural mechanisms of inhibiting \u03b1-synuclein aggregation by novel analogs of nordihydroguaiaretic acid (NDGA), a phenolic dibenzenediol lignan, were explored using an array of biochemical and biophysical methodologies. NDGA analogs induced modest, progressive compaction of monomeric \u03b1-synuclein, preventing aggregation into amyloid-like fibrils. This conformational remodeling preserved the dynamic adoption of \u03b1-helical conformations, which are essential for physiological membrane interactions. Oxidation-dependent NDGA cyclization was required for the interaction with monomeric \u03b1-synuclein. NDGA analog-pretreated \u03b1-synuclein did not aggregate even without NDGA-analogs in the aggregation mixture. Strikingly, NDGA-pretreated \u03b1-synuclein suppressed aggregation of na\u00efve untreated aggregation-competent monomeric \u03b1-synuclein. Further, cyclized NDGA reduced \u03b1-synuclein-driven neurodegeneration in <jats:italic>Caenorhabditis elegans<\/jats:italic>. The cyclized NDGA analogs may serve as a platform for the development of small molecules that stabilize aggregation-resistant \u03b1-synuclein monomers without interfering with functional conformations yielding potential therapies for PD and related disorders.<\/jats:p>","DOI":"10.1038\/s41598-019-39480-z","type":"journal-article","created":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T11:27:43Z","timestamp":1551266863000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Cyclized NDGA modifies dynamic \u03b1-synuclein monomers preventing aggregation and toxicity"],"prefix":"10.1038","volume":"9","author":[{"given":"Malcolm J.","family":"Daniels","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"J. Brucker","family":"Nourse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerio","family":"Sainati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Schiavina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Murrali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buyan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Ferrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conor M.","family":"Haney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rani","family":"Moons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal S.","family":"Gould","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1489-272X","authenticated-orcid":false,"given":"Antonino","family":"Natalello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Grandori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Sobott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. James","family":"Petersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Rhoades","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7755-0885","authenticated-orcid":false,"given":"Roberta","family":"Pierattelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6018-9090","authenticated-orcid":false,"given":"Isabella","family":"Felli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4037-5857","authenticated-orcid":false,"given":"Vladimir N.","family":"Uversky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim A.","family":"Caldwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy A.","family":"Caldwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward S.","family":"Krol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Ischiropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,27]]},"reference":[{"key":"39480_CR1","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini, M. G. et al. alpha-Synuclein in Lewy bodies. Nature 388, 839\u2013840 (1997).","journal-title":"Nature"},{"key":"39480_CR2","first-page":"879","volume":"152","author":"M Baba","year":"1998","unstructured":"Baba, M. et al. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson\u2019s disease and dementia with Lewy bodies. Am. J. Pathol. 152, 879\u201384 (1998).","journal-title":"Am. J. Pathol."},{"key":"39480_CR3","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos, M. H. et al. Mutation in the \u03b1-synuclein gene identified in families with Parkinson\u2019s disease. Science 276, 2045\u20132047 (1997).","journal-title":"Science"},{"key":"39480_CR4","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/ng0298-106","volume":"18","author":"R Kr\u00fcger","year":"1998","unstructured":"Kr\u00fcger, R. et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson\u2019s disease. Nat. Genet. 18, 106\u2013108 (1998).","journal-title":"Nat. Genet."},{"key":"39480_CR5","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","volume":"364","author":"MC Chartier-Harlin","year":"2004","unstructured":"Chartier-Harlin, M. C. et al. \u03b1-synuclein locus duplication as a cause of familial Parkinson\u2019s disease. Lancet 364, 1167\u20131169 (2004).","journal-title":"Lancet"},{"key":"39480_CR6","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1090278","volume":"302","author":"AB Singleton","year":"2003","unstructured":"Singleton, A. B. et al. \u03b1-Synuclein Locus Triplication Causes Parkinson\u2019s Disease. Science 302, 841 (2003).","journal-title":"Science"},{"key":"39480_CR7","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S0304-3940(98)00407-8","volume":"249","author":"K Wakabayashi","year":"1998","unstructured":"Wakabayashi, K., Yoshimoto, M., Tsuji, S. & Takahashi, H. Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci. Lett. 249, 180\u20132 (1998).","journal-title":"Neurosci. Lett."},{"key":"39480_CR8","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","volume":"95","author":"MG Spillantini","year":"1998","unstructured":"Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M. & Goedert, M. alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with lewy bodies. Proc. Natl. Acad. Sci. USA 95, 6469\u201373 (1998).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"39480_CR9","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S0140-6736(05)79256-4","volume":"352","author":"WP Gai","year":"1998","unstructured":"Gai, W. P., Power, J. H., Blumbergs, P. C. & Blessing, W. W. Multiple-system atrophy: a new alpha-synuclein disease? Lancet (London, England) 352, 547\u20138 (1998).","journal-title":"Lancet (London, England)"},{"key":"39480_CR10","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/sj.cdd.4400432","volume":"5","author":"JQ Trojanowski","year":"1998","unstructured":"Trojanowski, J. Q., Goedert, M., Iwatsubo, T. & Lee, V. M. Fatal attractions: abnormal protein aggregation and neuron death in Parkinson\u2019s disease and Lewy body dementia. Cell Death Differ. 5, 832\u20137 (1998).","journal-title":"Cell Death Differ."},{"key":"39480_CR11","first-page":"367","volume":"152","author":"A Takeda","year":"1998","unstructured":"Takeda, A. et al. Abnormal accumulation of NACP\/\u03b1-synuclein in neurodegenerative disorders. Am. J. Pathol. 152, 367\u2013372 (1998).","journal-title":"Am. J. Pathol."},{"key":"39480_CR12","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1007\/PL00000671","volume":"57","author":"CB L\u00fccking","year":"2000","unstructured":"L\u00fccking, C. B. & Brice, A. Alpha-synuclein and Parkinson\u2019s disease. Cell. Mol. life Sci. 57, 1894\u2013908 (2000).","journal-title":"Cell. Mol. life Sci."},{"key":"39480_CR13","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1212\/WNL.51.3.887","volume":"51","author":"S Arawaka","year":"1998","unstructured":"Arawaka, S., Saito, Y., Murayama, S. & Mori, H. Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for alpha-synuclein. Neurology 51, 887\u20139 (1998).","journal-title":"Neurology"},{"key":"39480_CR14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0304-3940(97)00891-4","volume":"239","author":"K Wakabayashi","year":"1997","unstructured":"Wakabayashi, K., Matsumoto, K., Takayama, K., Yoshimoto, M. & Takahashi, H. NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson\u2019s disease. Neurosci. Lett. 239, 45\u20138 (1997).","journal-title":"Neurosci. Lett."},{"key":"39480_CR15","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0896-6273(00)80886-7","volume":"25","author":"A Abeliovich","year":"2000","unstructured":"Abeliovich, A. et al. Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 25, 239\u201352 (2000).","journal-title":"Neuron"},{"key":"39480_CR16","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1016\/j.bpj.2010.07.056","volume":"99","author":"ER Middleton","year":"2010","unstructured":"Middleton, E. R. & Rhoades, E. Effects of curvature and composition on \u03b1-synuclein binding to lipid vesicles. Biophys. J. 99, 2279\u20132288 (2010).","journal-title":"Biophys. J."},{"key":"39480_CR17","doi-asserted-by":"publisher","first-page":"11915","DOI":"10.1523\/JNEUROSCI.3821-06.2006","volume":"26","author":"KE Larsen","year":"2006","unstructured":"Larsen, K. E. et al. Alpha-synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis. J. Neurosci. 26, 11915\u201322 (2006).","journal-title":"J. Neurosci."},{"key":"39480_CR18","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.neuron.2009.12.023","volume":"65","author":"VM Nemani","year":"2010","unstructured":"Nemani, V. M. et al. Increased Expression of \u03b1-Synuclein Reduces Neurotransmitter Release by Inhibiting Synaptic Vesicle Reclustering after Endocytosis. Neuron 65, 66\u201379 (2010).","journal-title":"Neuron"},{"key":"39480_CR19","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1523\/JNEUROSCI.20-09-03214.2000","volume":"20","author":"DD Murphy","year":"2000","unstructured":"Murphy, D. D., Rueter, S. M., Trojanowski, J. Q. & Lee, V. M. Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons. J. Neurosci. 20, 3214\u20133220 (2000).","journal-title":"J. Neurosci."},{"key":"39480_CR20","doi-asserted-by":"publisher","first-page":"19573","DOI":"10.1073\/pnas.1005005107","volume":"107","author":"B Greten-Harrison","year":"2010","unstructured":"Greten-Harrison, B. et al. \u03b1-Synuclein triple knockout mice reveal age-dependent neuronal dysfunction. Proc. Natl. Acad. Sci. 107, 19573\u201319578 (2010).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"39480_CR21","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.0535-12.2012","volume":"32","author":"D Scott","year":"2012","unstructured":"Scott, D. & Roy, S. \u03b1-Synuclein inhibits intersynaptic vesicle mobility and maintains recycling-pool homeostasis. J. Neurosci. 32, 10129\u201335 (2012).","journal-title":"J. Neurosci."},{"key":"39480_CR22","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0896-6273(02)00682-7","volume":"34","author":"BI Giasson","year":"2002","unstructured":"Giasson, B. I. et al. Neuronal \u03b1-synucleinopathy with severe movement disorder in mice expressing A53T human \u03b1-synuclein. Neuron 34, 521\u2013533 (2002).","journal-title":"Neuron"},{"key":"39480_CR23","doi-asserted-by":"publisher","first-page":"8345","DOI":"10.1523\/JNEUROSCI.0772-15.2015","volume":"35","author":"W Yang","year":"2015","unstructured":"Yang, W. et al. Mutant Alpha-Synuclein Causes Age-Dependent Neuropathology in Monkey Brain. J. Neurosci. 35, 8345\u20138358 (2015).","journal-title":"J. Neurosci."},{"key":"39480_CR24","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/ana.24066","volume":"75","author":"A Recasens","year":"2014","unstructured":"Recasens, A. et al. Lewy body extracts from Parkinson disease brains trigger \u03b1-synuclein pathology and neurodegeneration in mice and monkeys. Ann. Neurol. 75, 351\u201362 (2014).","journal-title":"Ann. Neurol."},{"key":"39480_CR25","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1126\/science.1227157","volume":"338","author":"KC Luk","year":"2012","unstructured":"Luk, K. C. et al. Pathological \u03b1-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 338, 949\u2013953 (2012).","journal-title":"Science"},{"key":"39480_CR26","doi-asserted-by":"publisher","first-page":"12368","DOI":"10.1523\/JNEUROSCI.2102-14.2014","volume":"34","author":"AN Sacino","year":"2014","unstructured":"Sacino, A. N. et al. Brain Injection of \u03b1-Synuclein Induces Multiple Proteinopathies, Gliosis, and a Neuronal Injury Marker. J. Neurosci. 34, 12368\u201312378 (2014).","journal-title":"J. Neurosci."},{"key":"39480_CR27","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40478-017-0413-0","volume":"5","author":"A Shimozawa","year":"2017","unstructured":"Shimozawa, A. et al. Propagation of pathological \u03b1-synuclein in marmoset brain. Acta Neuropathol. Commun. 5, 12 (2017).","journal-title":"Acta Neuropathol. Commun."},{"key":"39480_CR28","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00401-017-1792-9","volume":"135","author":"NL Rey","year":"2018","unstructured":"Rey, N. L. et al. Spread of aggregates after olfactory bulb injection of \u03b1-synuclein fibrils is associated with early neuronal loss and is reduced long term. Acta Neuropathol. 135, 65\u201383 (2018).","journal-title":"Acta Neuropathol."},{"key":"39480_CR29","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/nm1746","volume":"14","author":"JY Li","year":"2008","unstructured":"Li, J. Y. et al. Lewy bodies in grafted neurons in subjects with Parkinson\u2019s disease suggest host-to-graft disease propagation. Nat. Med. 14, 501\u2013503 (2008).","journal-title":"Nat. Med."},{"key":"39480_CR30","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1097\/00001756-200001170-00041","volume":"11","author":"NW Kowall","year":"2000","unstructured":"Kowall, N. W. et al. MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons. Neuroreport 11, 211\u2013213 (2000).","journal-title":"Neuroreport"},{"key":"39480_CR31","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/81834","volume":"3","author":"R Betarbet","year":"2000","unstructured":"Betarbet, R. et al. Chronic systemic pesticide exposure reproduces features of Parkinson\u2019s disease. Nat. Neurosci. 3, 1301\u20131306 (2000).","journal-title":"Nat. Neurosci."},{"key":"39480_CR32","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1126\/science.1063522","volume":"294","author":"KA Conway","year":"2001","unstructured":"Conway, K. A., Rochet, J. C., Bieganski, R. M. & Lansbury, J. Kinetic stabilization of the \u03b1-synuclein protofibril by a dopamine-\u03b1-synuclein adduct. Science 294, 1346\u20131349 (2001).","journal-title":"Science"},{"key":"39480_CR33","doi-asserted-by":"publisher","first-page":"21212","DOI":"10.1074\/jbc.M412621200","volume":"280","author":"EH Norris","year":"2005","unstructured":"Norris, E. H. et al. Reversible inhibition of \u03b1-synuclein fibrillization by dopaminochrome-mediated conformational alterations. J. Biol. Chem. 280, 21212\u201321219 (2005).","journal-title":"J. Biol. Chem."},{"key":"39480_CR34","doi-asserted-by":"publisher","first-page":"10068","DOI":"10.1523\/JNEUROSCI.0896-06.2006","volume":"26","author":"JR Mazzulli","year":"2006","unstructured":"Mazzulli, J. R. et al. Cytosolic Catechols Inhibit \u03b1-Synuclein Aggregation and Facilitate the Formation of Intracellular Soluble Oligomeric Intermediates. J. Neurosci. 26, 10068\u201310078 (2006).","journal-title":"J. Neurosci."},{"key":"39480_CR35","doi-asserted-by":"publisher","first-page":"8206","DOI":"10.1021\/bi900506b","volume":"48","author":"X Meng","year":"2009","unstructured":"Meng, X., Munishkina, L. A., Fink, A. L. & Uversky, V. N. Molecular mechanisms underlying the flavonoid-induced inhibition of \u03b1-synuclein fibrillation. Biochemistry 48, 8206\u20138224 (2009).","journal-title":"Biochemistry"},{"key":"39480_CR36","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1038\/nn.4641","volume":"20","author":"DE Mor","year":"2017","unstructured":"Mor, D. E. et al. Dopamine induces soluble \u03b1-synuclein oligomers and nigrostriatal degeneration. Nat. Neurosci. 20, 1560\u20131568 (2017).","journal-title":"Nat. Neurosci."},{"key":"39480_CR37","doi-asserted-by":"publisher","first-page":"9220","DOI":"10.1523\/JNEUROSCI.2617-07.2007","volume":"27","author":"KM Danzer","year":"2007","unstructured":"Danzer, K. M. et al. Different Species of \u03b1-Synuclein Oligomers Induce Calcium Influx and Seeding. J. Neurosci. 27, 9220\u20139232 (2007).","journal-title":"J. Neurosci."},{"key":"39480_CR38","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1126\/science.aam9080","volume":"357","author":"LF Burbulla","year":"2017","unstructured":"Burbulla, L. F. et al. Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson\u2019s disease. Science 357, 1255\u20131261 (2017).","journal-title":"Science"},{"key":"39480_CR39","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/nsmb.1437","volume":"15","author":"DE Ehrnhoefer","year":"2008","unstructured":"Ehrnhoefer, D. E. et al. EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers. Nat. Struct. Mol. Biol. 15, 558\u2013566 (2008).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"39480_CR40","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1471-4159.2006.03707.x","volume":"97","author":"K Ono","year":"2006","unstructured":"Ono, K. & Yamada, M. Antioxidant compounds have potent anti-fibrillogenic and fibril-destabilizing effects for alpha-synuclein fibrils in vitro. J. Neurochem. 97, 105\u201315 (2006).","journal-title":"J. Neurochem."},{"key":"39480_CR41","doi-asserted-by":"publisher","first-page":"6085","DOI":"10.1021\/bi0600749","volume":"45","author":"M Masuda","year":"2006","unstructured":"Masuda, M. et al. Small molecule inhibitors of \u03b1-synuclein filament assembly. Biochemistry 45, 6085\u20136094 (2006).","journal-title":"Biochemistry"},{"key":"39480_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4061\/2010\/650794","volume":"2010","author":"X Meng","year":"2010","unstructured":"Meng, X., Munishkina, L. A., Fink, A. L. & Uversky, V. N. Effects of Various Flavonoids on the \u03b1-Synuclein Fibrillation Process. Parkinsons. Dis. 2010, 1\u201316 (2010).","journal-title":"Parkinsons. Dis."},{"key":"39480_CR43","doi-asserted-by":"publisher","unstructured":"Fernandes, L. et al. An ortho-Iminoquinone Compound Reacts with Lysine Inhibiting Aggregation while Remodeling Mature Amyloid Fibrils. ACS Chem. Neurosci. acschemneuro.7b00017, https:\/\/doi.org\/10.1021\/acschemneuro.7b00017 (2017).","DOI":"10.1021\/acschemneuro.7b00017"},{"key":"39480_CR44","doi-asserted-by":"publisher","first-page":"14941","DOI":"10.1074\/jbc.M109.080390","volume":"285","author":"S Di Giovanni","year":"2010","unstructured":"Di Giovanni, S. et al. Entacapone and tolcapone, two catechol O-methyltransferase inhibitors, block fibril formation of \u03b1-synuclein and \u03b2-amyloid and protect against amyloid-induced toxicity. J. Biol. Chem. 285, 14941\u201314954 (2010).","journal-title":"J. Biol. Chem."},{"key":"39480_CR45","doi-asserted-by":"publisher","first-page":"21299","DOI":"10.1074\/jbc.M114.554667","volume":"289","author":"N Lorenzen","year":"2014","unstructured":"Lorenzen, N. et al. How epigallocatechin gallate can inhibit \u03b1-synuclein oligomer toxicity in vitro. J. Biol. Chem. 289, 21299\u201321310 (2014).","journal-title":"J. Biol. Chem."},{"key":"39480_CR46","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s00401-013-1114-9","volume":"125","author":"J Wagner","year":"2013","unstructured":"Wagner, J. et al. Anle138b: A novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson\u2019s disease. Acta Neuropathol. 125, 795\u2013813 (2013).","journal-title":"Acta Neuropathol."},{"key":"39480_CR47","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1016\/j.bbagen.2015.05.021","volume":"1850","author":"AA Deeg","year":"2015","unstructured":"Deeg, A. A. et al. Anle138b and related compounds are aggregation specific fluorescence markers and reveal high affinity binding to \u03b1-synuclein aggregates. Biochim. Biophys. Acta 1850, 1884\u201390 (2015).","journal-title":"Biochim. Biophys. Acta"},{"key":"39480_CR48","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/j.chembiol.2004.08.025","volume":"11","author":"J Li","year":"2004","unstructured":"Li, J., Zhu, M., Rajamani, S., Uversky, V. N. & Fink, A. L. Rifampicin inhibits alpha-synuclein fibrillation and disaggregates fibrils. Chem. Biol. 11, 1513\u201321 (2004).","journal-title":"Chem. Biol."},{"key":"39480_CR49","doi-asserted-by":"publisher","first-page":"8468","DOI":"10.1021\/acs.analchem.6b00731","volume":"88","author":"A Konijnenberg","year":"2016","unstructured":"Konijnenberg, A. et al. Opposite Structural Effects of Epigallocatechin-3-gallate and Dopamine Binding to \u03b1-Synuclein. Anal. Chem. 88, 8468\u20138475 (2016).","journal-title":"Anal. Chem."},{"key":"39480_CR50","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.1093\/brain\/aww238","volume":"139","author":"W Wrasidlo","year":"2016","unstructured":"Wrasidlo, W. et al. A de novo compound targeting \u03b1-synuclein improves deficits in models of Parkinson\u2019s disease. Brain 139, 3217\u20133236 (2016).","journal-title":"Brain"},{"key":"39480_CR51","doi-asserted-by":"publisher","first-page":"E1009","DOI":"10.1073\/pnas.1610586114","volume":"114","author":"M Perni","year":"2017","unstructured":"Perni, M. et al. A natural product inhibits the initiation of \u03b1-synuclein aggregation and suppresses its toxicity. Proc. Natl. Acad. Sci. 114, E1009\u2013E1017 (2017).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"39480_CR52","doi-asserted-by":"publisher","first-page":"3704","DOI":"10.1021\/bi0356707","volume":"43","author":"E-N Lee","year":"2004","unstructured":"Lee, E.-N. et al. Phthalocyanine tetrasulfonates affect the amyloid formation and cytotoxicity of alpha-synuclein. Biochemistry 43, 3704\u201315 (2004).","journal-title":"Biochemistry"},{"key":"39480_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6857","volume":"5","author":"L Fonseca-Ornelas","year":"2014","unstructured":"Fonseca-Ornelas, L. et al. Small molecule-mediated stabilization of vesicle-associated helical \u03b1-synuclein inhibits pathogenic misfolding and aggregation. Nat. Commun. 5, 5857 (2014).","journal-title":"Nat. Commun."},{"key":"39480_CR54","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1096\/fj.10-164624","volume":"25","author":"KM Danzer","year":"2011","unstructured":"Danzer, K. M. et al. Heat-shock protein 70 modulates toxic extracellular \u03b1-synuclein oligomers and rescues trans-synaptic toxicity. FASEB J. 25, 326\u2013336 (2011).","journal-title":"FASEB J."},{"key":"39480_CR55","doi-asserted-by":"publisher","first-page":"27582","DOI":"10.1074\/jbc.M114.636027","volume":"290","author":"B Moree","year":"2015","unstructured":"Moree, B. et al. Small molecules detected by second-harmonic generation modulate the conformation of monomeric \u03b1-synuclein and reduce its aggregation in cells. J. Biol. Chem. 290, 27582\u201327593 (2015).","journal-title":"J. Biol. Chem."},{"key":"39480_CR56","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.nbd.2017.07.007","volume":"106","author":"TJ Collier","year":"2017","unstructured":"Collier, T. J. et al. Nortriptyline inhibits aggregation and neurotoxicity of alpha-synuclein by enhancing reconfiguration of the monomeric form. Neurobiol. Dis. 106, 191\u2013204 (2017).","journal-title":"Neurobiol. Dis."},{"key":"39480_CR57","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1007\/s13311-012-0105-1","volume":"9","author":"S Prabhudesai","year":"2012","unstructured":"Prabhudesai, S. et al. A Novel \u2018Molecular Tweezer\u2019 Inhibitor of \u03b1-Synuclein Neurotoxicity in Vitro and in Vivo. Neurotherapeutics 9, 464\u2013476 (2012).","journal-title":"Neurotherapeutics"},{"key":"39480_CR58","doi-asserted-by":"publisher","first-page":"10727","DOI":"10.1074\/jbc.M113.524520","volume":"289","author":"S Acharya","year":"2014","unstructured":"Acharya, S. et al. Molecular basis for preventing \u03b1-synuclein aggregation by a molecular tweezer. J. Biol. Chem. 289, 10727\u201310737 (2014).","journal-title":"J. Biol. Chem."},{"key":"39480_CR59","doi-asserted-by":"publisher","first-page":"E4274","DOI":"10.1073\/pnas.1416598111","volume":"111","author":"J Burr\u00e9","year":"2014","unstructured":"Burr\u00e9, J., Sharma, M. & S\u00fcdhof, T. C. \u03b1-Synuclein assembles into higher-order multimers upon membrane binding to promote SNARE complex formation. Proc. Natl. Acad. Sci. 111, E4274\u2013E4283 (2014).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"39480_CR60","doi-asserted-by":"publisher","first-page":"3466","DOI":"10.1093\/hmg\/ddx227","volume":"26","author":"U Dettmer","year":"2017","unstructured":"Dettmer, U. et al. Loss of native \u03b1-synuclein multimerization by strategically mutating its amphipathic helix causes abnormal vesicle interactions in neuronal cells. Hum. Mol. Genet. 26, 3466\u20133481 (2017).","journal-title":"Hum. Mol. Genet."},{"key":"39480_CR61","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1042\/BCJ20170200","volume":"474","author":"X Lou","year":"2017","unstructured":"Lou, X., Kim, J., Hawk, B. J. & Shin, Y.-K. \u03b1-Synuclein may cross-bridge v-SNARE and acidic phospholipids to facilitate SNARE-dependent vesicle docking. Biochem. J. 474, 2039\u20132049 (2017).","journal-title":"Biochem. J."},{"key":"39480_CR62","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.febslet.2011.03.046","volume":"585","author":"M Caruana","year":"2011","unstructured":"Caruana, M. et al. Inhibition and disaggregation of \u03b1-synuclein oligomers by natural polyphenolic compounds. FEBS Lett. 585, 1113\u20131120 (2011).","journal-title":"FEBS Lett."},{"key":"39480_CR63","doi-asserted-by":"publisher","first-page":"7007","DOI":"10.1016\/j.bmc.2015.09.039","volume":"23","author":"I Asiamah","year":"2015","unstructured":"Asiamah, I., Hodgson, H. L., Maloney, K., Allen, K. J. H. & Krol, E. S. Ring substitution influences oxidative cyclisation and reactive metabolite formation of nordihydroguaiaretic acid analogues. Bioorganic Med. Chem. 23, 7007\u20137014 (2015).","journal-title":"Bioorganic Med. Chem."},{"key":"39480_CR64","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1021\/acs.analchem.5b04420","volume":"88","author":"JR Mazzulli","year":"2016","unstructured":"Mazzulli, J. R., Burbulla, L. F., Krainc, D. & Ischiropoulos, H. Detection of Free and Protein-Bound ortho-Quinones by Near-Infrared Fluorescence. Anal. Chem. 88, 2399\u2013405 (2016).","journal-title":"Anal. Chem."},{"key":"39480_CR65","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s13361-016-1490-1","volume":"28","author":"A Natalello","year":"2017","unstructured":"Natalello, A., Santambrogio, C. & Grandori, R. Are Charge-State Distributions a Reliable Tool Describing Molecular Ensembles of Intrinsically Disordered Proteins by Native MS? J. Am. Soc. Mass Spectrom. 28, 21\u201328 (2017).","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"39480_CR66","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.bpj.2017.11.006","volume":"114","author":"JJ Ferrie","year":"2018","unstructured":"Ferrie, J. J. et al. Using a FRET Library with Multiple Probe Pairs To Drive Monte Carlo Simulations of \u03b1-Synuclein. Biophys. J. 114, 53\u201364 (2018).","journal-title":"Biophys. J."},{"key":"39480_CR67","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/0896-6273(95)90040-3","volume":"15","author":"JM George","year":"1995","unstructured":"George, J. M., Jin, H., Woods, W. S. & Clayton, D. F. Characterization of a novel protein regulated during the critical period for song learning in the zebra finch. Neuron 15, 361\u2013372 (1995).","journal-title":"Neuron"},{"key":"39480_CR68","doi-asserted-by":"publisher","first-page":"9443","DOI":"10.1074\/jbc.273.16.9443","volume":"273","author":"WS Davidson","year":"1998","unstructured":"Davidson, W. S., Jonas, A., Clayton, D. F. & George, J. M. Stabilization of \u03b1-Synuclein secondary structure upon binding to synthetic membranes. J. Biol. Chem. 273, 9443\u20139449 (1998).","journal-title":"J. Biol. Chem."},{"key":"39480_CR69","doi-asserted-by":"publisher","first-page":"43179","DOI":"10.1074\/jbc.M507624200","volume":"280","author":"TS Ulmer","year":"2005","unstructured":"Ulmer, T. S. & Bax, A. Comparison of structure and dynamics of micelle-bound human \u03b1-synuclein and Parkinson disease variants. J. Biol. Chem. 280, 43179\u201343187 (2005).","journal-title":"J. Biol. Chem."},{"key":"39480_CR70","doi-asserted-by":"publisher","first-page":"4692","DOI":"10.1529\/biophysj.105.079251","volume":"90","author":"E Rhoades","year":"2006","unstructured":"Rhoades, E., Ramlall, T. F., Webb, W. W. & Eliezer, D. Quantification of \u03b1-synuclein binding to lipid vesicles using fluorescence correlation spectroscopy. Biophys. J. 90, 4692\u20134700 (2006).","journal-title":"Biophys. J."},{"key":"39480_CR71","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.gde.2017.02.011","volume":"44","author":"BA Martinez","year":"2017","unstructured":"Martinez, B. A., Caldwell, K. A. & Caldwell, G. A. C. elegans as a model system to accelerate discovery for Parkinson disease. Curr. Opin. Genet. Dev. 44, 102\u2013109 (2017).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"39480_CR72","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1073\/pnas.0711018105","volume":"105","author":"S Hamamichi","year":"2008","unstructured":"Hamamichi, S. et al. Hypothesis-based RNAi screening identifies neuroprotective genes in a Parkinson\u2019s disease model. Proc. Natl. Acad. Sci. USA 105, 728\u2013733 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"39480_CR73","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.1172\/JCI64502","volume":"125","author":"AD Zharikov","year":"2015","unstructured":"Zharikov, A. D. et al. shRNA targeting \u03b1-synuclein prevents neurodegeneration in a Parkinson\u2019s disease model. J. Clin. Invest. 125, 2721\u20132735 (2015).","journal-title":"J. Clin. Invest."},{"key":"39480_CR74","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1523\/JNEUROSCI.3809-03.2004","volume":"24","author":"H-J Lee","year":"2004","unstructured":"Lee, H.-J. Clearance of \u03b1-Synuclein Oligomeric Intermediates via the Lysosomal Degradation Pathway. J. Neurosci. 24, 1888\u20131896 (2004).","journal-title":"J. Neurosci."},{"key":"39480_CR75","doi-asserted-by":"publisher","first-page":"12535","DOI":"10.1523\/JNEUROSCI.1920-10.2010","volume":"30","author":"B Dehay","year":"2010","unstructured":"Dehay, B. et al. Pathogenic Lysosomal Depletion in Parkinson\u2019s Disease. J. Neurosci. 30, 12535\u201312544 (2010).","journal-title":"J. Neurosci."},{"key":"39480_CR76","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.neuron.2005.05.010","volume":"46","author":"E Masliah","year":"2005","unstructured":"Masliah, E. et al. Effects of alpha-synuclein immunization in a mouse model of Parkinson\u2019s disease. Neuron 46, 857\u201368 (2005).","journal-title":"Neuron"},{"key":"39480_CR77","doi-asserted-by":"crossref","unstructured":"Masliah, E. et al. Passive immunization reduces behavioral and neuropathological deficits in an alpha-synuclein transgenic model of lewy body disease. PLoS One 6 (2011).","DOI":"10.1371\/journal.pone.0019338"},{"key":"39480_CR78","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00702-016-1507-8","volume":"123","author":"J Levin","year":"2016","unstructured":"Levin, J. et al. The PROMESA-protocol: progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approach. J. Neural Transm. 123, 439\u201345 (2016).","journal-title":"J. Neural Transm."},{"key":"39480_CR79","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1159\/000265946","volume":"7","author":"L Reznichenko","year":"2010","unstructured":"Reznichenko, L., Kalfon, L., Amit, T., Youdim, M. B. H. & Mandel, S. A. Low dosage of rasagiline and epigallocatechin gallate synergistically restored the nigrostriatal axis in MPTP-induced parkinsonism. Neurodegener. Dis. 7, 219\u2013231 (2010).","journal-title":"Neurodegener. Dis."},{"key":"39480_CR80","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.neuroscience.2014.12.003","volume":"286","author":"M Chen","year":"2015","unstructured":"Chen, M. et al. Tea polyphenols alleviate motor impairments, dopaminergic neuronal injury, and cerebral \u03b1-synuclein aggregation in MPTP-intoxicated parkinsonian monkeys. Neuroscience 286, 383\u2013392 (2015).","journal-title":"Neuroscience"},{"key":"39480_CR81","doi-asserted-by":"crossref","unstructured":"Thomas, B. et al. Resistance to MPTP-Neurotoxicity in \u03b1-synuclein knockout mice is complemented by human \u03b1-synuclein and associated with increased \u03b2-synuclein and Akt activation. PLoS One 6 (2011).","DOI":"10.1371\/journal.pone.0016706"},{"key":"39480_CR82","doi-asserted-by":"publisher","first-page":"7710","DOI":"10.1073\/pnas.0910723107","volume":"107","author":"J Bieschke","year":"2010","unstructured":"Bieschke, J. et al. EGCG remodels mature \u03b1-synuclein and amyloid-\u03b2 fibrils and reduces cellular toxicity. Proc. Natl. Acad. Sci. 107, 7710\u20137715 (2010).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"39480_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-016-0028-x","volume":"7","author":"JE Yang","year":"2017","unstructured":"Yang, J. E. et al. EGCG-mediated Protection of the Membrane Disruption and Cytotoxicity Caused by the \u2018Active Oligomer\u2019 of \u03b1-Synuclein. Sci. Rep. 7, 1\u201310 (2017).","journal-title":"Sci. Rep."},{"key":"39480_CR84","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.brainres.2016.09.020","volume":"1651","author":"L Poga\u010dnik","year":"2016","unstructured":"Poga\u010dnik, L. et al. Potential for brain accessibility and analysis of stability of selected flavonoids in relation to neuroprotection in vitro. Brain Res. 1651, 17\u201326 (2016).","journal-title":"Brain Res."},{"key":"39480_CR85","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.fct.2009.10.030","volume":"48","author":"JD Lambert","year":"2010","unstructured":"Lambert, J. D. et al. Hepatotoxicity of high oral dose (\u2212)-epigallocatechin-3-gallate in mice. Food Chem. Toxicol. 48, 409\u2013416 (2010).","journal-title":"Food Chem. Toxicol."},{"key":"39480_CR86","doi-asserted-by":"publisher","first-page":"16873","DOI":"10.1074\/jbc.M210136200","volume":"278","author":"M Zhu","year":"2003","unstructured":"Zhu, M. & Fink, A. L. Lipid binding inhibits \u03b1-synuclein fibril formation. J. Biol. Chem. 278, 16873\u201316877 (2003).","journal-title":"J. Biol. Chem."},{"key":"39480_CR87","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1126\/science.1195227","volume":"329","author":"J Burr\u00e9","year":"2010","unstructured":"Burr\u00e9, J. et al. \u03b1-Synuclein promotes SNARE-complex assembly in vivo and in vitro. Science 329, 1663\u20131667 (2010).","journal-title":"Science"},{"key":"39480_CR88","first-page":"201700465","volume":"115","author":"S Kim","year":"2018","unstructured":"Kim, S. et al. GBA1 deficiency negatively affects physiological \u03b1-synuclein tetramers and related multimers. Proc. Natl. Acad. Sci. 115, 201700465 (2018).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"39480_CR89","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8314","volume":"6","author":"U Dettmer","year":"2015","unstructured":"Dettmer, U. et al. Parkinson-causing \u03b1-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation. Nat. Commun. 6, 7314 (2015).","journal-title":"Nat. Commun."},{"key":"39480_CR90","doi-asserted-by":"publisher","first-page":"4294","DOI":"10.1073\/pnas.0407881102","volume":"102","author":"RM Rasia","year":"2005","unstructured":"Rasia, R. M. et al. Structural characterization of copper(II) binding to \u03b1-synuclein: Insights into the bioinorganic chemistry of Parkinson\u2019s disease. Proc. Natl. Acad. Sci. 102, 4294\u20134299 (2005).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"39480_CR91","doi-asserted-by":"publisher","first-page":"9893","DOI":"10.1021\/ja0618649","volume":"128","author":"A Binolfi","year":"2006","unstructured":"Binolfi, A. et al. Interaction of \u03b1-synuclein with divalent metal ions reveals key differences: A link between structure, binding specificity and fibrillation enhancement. J. Am. Chem. Soc. 128, 9893\u20139901 (2006).","journal-title":"J. Am. Chem. Soc."},{"key":"39480_CR92","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/mds.25421","volume":"28","author":"S Appel-Cresswell","year":"2013","unstructured":"Appel-Cresswell, S. et al. Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson\u2019s disease. Mov. Disord. 28, 811\u2013813 (2013).","journal-title":"Mov. Disord."},{"key":"39480_CR93","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1212\/WNL.0b013e31828727ba","volume":"80","author":"C Proukakis","year":"2013","unstructured":"Proukakis, C. et al. A novel \u03b1-synuclein missense mutation in Parkinson disease. Neurology 80, 1062\u20131064 (2013).","journal-title":"Neurology"},{"key":"39480_CR94","doi-asserted-by":"publisher","first-page":"6925","DOI":"10.1021\/bi400999d","volume":"52","author":"D Ghosh","year":"2013","unstructured":"Ghosh, D. et al. The parkinson\u2019s disease-associated H50Q mutation accelerates \u03b1-synuclein aggregation in vitro. Biochemistry 52, 6925\u20136927 (2013).","journal-title":"Biochemistry"},{"key":"39480_CR95","doi-asserted-by":"publisher","unstructured":"Kowalik-Jankowska, T., Rajewska, A., Jankowska, E. & Grzonka, Z. Copper(II) binding by fragments of alpha-synuclein containing M1-D2- and -H50-residues; a combined potentiometric and spectroscopic study. Dalton Trans. 5068\u201376, https:\/\/doi.org\/10.1039\/b610619f (2006).","DOI":"10.1039\/b610619f"},{"key":"39480_CR96","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.freeradbiomed.2011.11.037","volume":"52","author":"P Back","year":"2012","unstructured":"Back, P. et al. Exploring real-time in vivo redox biology of developing and aging Caenorhabditis elegans. Free Radic. Biol. Med. 52, 850\u2013859 (2012).","journal-title":"Free Radic. Biol. Med."},{"key":"39480_CR97","doi-asserted-by":"publisher","first-page":"7390","DOI":"10.1021\/ja900616b","volume":"131","author":"DI Hammoudeh","year":"2009","unstructured":"Hammoudeh, D. I., Follis, A. V., Prochownik, E. V. & Metallo, S. J. Multiple independent binding sites for small-molecule inhibitors on the oncoprotein c-Myc. J. Am. Chem. Soc. 131, 7390\u2013401 (2009).","journal-title":"J. Am. Chem. Soc."},{"key":"39480_CR98","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.cbpa.2010.06.169","volume":"14","author":"SJ Metallo","year":"2010","unstructured":"Metallo, S. J. Intrinsically disordered proteins are potential drug targets. Curr. Opin. Chem. Biol. 14, 481\u20138 (2010).","journal-title":"Curr. Opin. Chem. Biol."},{"key":"39480_CR99","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.coph.2010.09.005","volume":"10","author":"AK Dunker","year":"2010","unstructured":"Dunker, A. K. & Uversky, V. N. Drugs for \u2018protein clouds\u2019: targeting intrinsically disordered transcription factors. Curr. Opin. Pharmacol. 10, 782\u20138 (2010).","journal-title":"Curr. Opin. Pharmacol."},{"key":"39480_CR100","doi-asserted-by":"publisher","first-page":"6151","DOI":"10.1038\/sj.onc.1206641","volume":"22","author":"X Yin","year":"2003","unstructured":"Yin, X., Giap, C., Lazo, J. S. & Prochownik, E. V. Low molecular weight inhibitors of Myc-Max interaction and function. Oncogene 22, 6151\u20139 (2003).","journal-title":"Oncogene"},{"key":"39480_CR101","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1158\/1535-7163.MCT-07-0005","volume":"6","author":"H Wang","year":"2007","unstructured":"Wang, H. et al. Improved low molecular weight Myc-Max inhibitors. Mol. Cancer Ther. 6, 2399\u2013408 (2007).","journal-title":"Mol. Cancer Ther."},{"key":"39480_CR102","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nature16531","volume":"530","author":"FX Theillet","year":"2016","unstructured":"Theillet, F. X. et al. Structural disorder of monomeric alpha-synuclein persists in mammalian cells. Nature 530, 45\u201350 (2016).","journal-title":"Nature"},{"key":"39480_CR103","doi-asserted-by":"publisher","first-page":"4194","DOI":"10.1073\/pnas.1100976108","volume":"108","author":"B Winner","year":"2011","unstructured":"Winner, B. et al. In vivo demonstration that \u03b1-synuclein oligomers are toxic. Proc. Natl. Acad. Sci. 108, 4194\u20134199 (2011).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"39480_CR104","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10858-010-9461-5","volume":"49","author":"A Favier","year":"2011","unstructured":"Favier, A. & Brutscher, B. Recovering lost magnetization: Polarization enhancement in biomolecular NMR. J. Biomol. NMR 49, 9\u201315 (2011).","journal-title":"J. Biomol. NMR"},{"key":"39480_CR105","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/978-3-319-20164-1_3","volume":"870","author":"B Brutscher","year":"2015","unstructured":"Brutscher, B. et al. NMR Methods for the Study of Instrinsically Disordered Proteins Structure, Dynamics, and Interactions: General Overview and Practical Guidelines. Adv. Exp. Med. Biol. 870, 49\u2013122 (2015).","journal-title":"Adv. Exp. Med. Biol."},{"key":"39480_CR106","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.pep.2005.02.014","volume":"42","author":"C Huang","year":"2005","unstructured":"Huang, C., Ren, G., Zhou, H. & Wang, C. C. A new method for purification of recombinant human \u03b1-synuclein in Escherichia coli. Protein Expr. Purif. 42, 173\u2013177 (2005).","journal-title":"Protein Expr. Purif."},{"key":"39480_CR107","doi-asserted-by":"publisher","unstructured":"Berkowitz, L. A., Knight, A. L., Caldwell, G. A. & Caldwell, K. A. Generation of Stable Transgenic C. elegans Using Microinjection. J. Vis. Exp. 3\u20135, https:\/\/doi.org\/10.3791\/833 (2008).","DOI":"10.3791\/833"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-39480-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-39480-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-39480-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T06:33:29Z","timestamp":1671258809000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-39480-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,27]]},"references-count":107,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["39480"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-39480-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,27]]},"assertion":[{"value":"22 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"2937"}}